BGA-006

N/A

Report date: 2022/05/10 11:41:05

NME

Base Information

Drug NameBGA-006

Drug Alias NameBGA006

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide

Mechanisms of ActionGenetic transcription inhibitorsAnaplastic lymphoma kinase inhibitors

TargetsAnaplastic lymphoma kinase

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiogenera SPA

China Registration ClassN/A

Active CompaniesBiogenera SPA

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

ATC CodeN/A